Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies.

Davis MS, Spencer RK, Johnson CE, Elhage KG, Jin JQ, Hakimi M, Bhutani T, Liao W

DOI: 10.1007/s13555-023-01074-z
Published: 2024 Jan
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-023-01074-z,
  title = {Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies.},
  author = {Davis MS and Spencer RK and Johnson CE and Elhage KG and Jin JQ and Hakimi M and Bhutani T and Liao W},
  year = {2024},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-023-01074-z},
  url = {https://doi.org/10.1007/s13555-023-01074-z}
}

RIS

TY  - JOUR
TI  - Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies.
AU  - Davis MS
AU  - Spencer RK
AU  - Johnson CE
AU  - Elhage KG
AU  - Jin JQ
AU  - Hakimi M
AU  - Bhutani T
AU  - Liao W
PY  - 2024
JO  - Dermatology and therapy
DO  - 10.1007/s13555-023-01074-z
UR  - https://doi.org/10.1007/s13555-023-01074-z
ER  -

APA

MS, D., RK, S., CE, J., KG, E., JQ, J., M, H., T, B., & W, L. (2024). Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies.. Dermatology and therapy. https://doi.org/10.1007/s13555-023-01074-z

Source records

pubmed · retrieved 2026-09-26T01:28:10.245Z